Blood Drops May Help Detect Early-Stage Lung Cancer
A study shows proof-of-concept of using a drop of blood to reveal lung cancer, which may help diagnose early-stage lung cancer in asymptomatic patients.
Read MorePosted by Andy Lundin | Dec 15, 2021 | Clinical Chemistry, Lung Cancer |
A study shows proof-of-concept of using a drop of blood to reveal lung cancer, which may help diagnose early-stage lung cancer in asymptomatic patients.
Read MorePosted by Andy Lundin | Dec 10, 2021 | Lung Cancer |
Thermo Fisher’s companion diagnostic test to identify targeted therapies for non-small cell lung cancer patients was granted premarket approval by the FDA.
Read MorePosted by Chris Wolski | Dec 9, 2021 | Diagnostic Technologies |
Industry experts predict a year of change and transformation ahead as the COVID-19 pandemic continues to influence the way clinical labs operate.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Cancer, Covid 19 |
Restrictions in access to care during the COVID-19 pandemic caused disruptions in the treatment and diagnoses of cancer and other conditions.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Lung Cancer |
Biocept’s liquid biopsy-based Target Selector NGS Lung Panel test aids genomic profiling in patients with advanced non-small cell lung cancer (NSCLC).
Read More